chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse practitioner (N.P.) concerning a 14 year old female with no pertinent medical history or drug reactions/allergies who on 16-MAR-2008 was vaccinated with a first dose of GARDASIL (lot# 659437/1266U) 0.5 mL IM.  There was no concomitant medication.  The N.P. mentioned that after receiving her first dose of GARDASIL on 16-MAR-2008 the patient has been experiencing episodic syncope with shortness of breath, numbness and tingling of the arms and then she passes out.  The patient's teachers have reported that she has limb movement similar to a seizure.  The episodes last about 5 to 10 minutes.  The N.P. mentioned that the patient has had 10 or more of these episodes since 12-APR-2008.  All the episodes have been witnessed at school, the episodes that occur at home have not been witnessed.  On 19-Apr-2008 a spirometry test was performed and demonstrated a mild obstruction consistent with mild asthma.  The patient was then placed on an albuterol inhaler.  Additional laboratory and diagnostic tests were performed the same day.  A chest X-ray, liver enzyme test, a kidney function and thyroid function test were normal.  The patient's blood lymphocyte count was slightly decreased and blood monocyte percent was slightly elevated.  The patient was seen in the emergency room the last week of April 2008 and was diagnosed with panic attacks.  The patient was sent to a cardiologist who stated that there was no cardiac underlying reason for the episodes and he believes that the patient was having panic attacks.  The patient was going to be sent to see a neurologist.  At the time of reporting the patient was recovering from syncope, shortness of breath, numbness of the arm, panic attack, tingling of the arm and tonic-clonic movements and the outcome of asthma was unknown.  No additional information was available.  Additional information has been requested.
Information has been received initially from a licensed practical nurse then in follow up from the female pt (age not reported), a licensed social worker, with allergies, asthma, kidney disorder, borderline diabetes and arthritis who on 19MAY2003 was vaccinated with a dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live (second generation). It was noted than an unspecified TB test was performed on the same day, 19MAY2003. Concomitant therapy included cetirizine hydrochloride taken from around 19MAY2003 for allergies, albuterol inhaler taken prn for asthma and lisinopril taken for her kidneys, pt is a borderline diabetic. About one week after vaccination, on approximately 26MAY2003, the pt developed wheezing, dry cough and hoarseness. Her primary care physician prescribed azithromycin which was started on 28MAY2003. On 02JUN2003 the pt awoke with itchy red spots like little bumps on face, chest and arms, not al of same size. It was noted that the pt was not able to see her primary care physician since then, but her rash was seen in passing by a registered nurse and physician that the pt works with. The pt noted that she has arthritis, but she has not had any pain for a while. Over the last week,from approximately 02JUN2003, the patient's knees have been very painful as well as other joints that are not usually affected, and she has had aches in all joints. At the time of this report, it was noted that the wheezing, aches in all joints and hoarseness were still continuing. The rash was still present, although it was noted to be getting lighter and was not as pronounced. The outcome for dry cough was not reported. Additional information has been requested.
Night of vaccination, I began to get in the middle of the night, feverish. Could not get out of bed. I had a severe headache, i was shivering, and my arm was killing me. I was so nauseous, couldn't take anything for my head. I could not get out of bed. Finally around 5-6 am, i managed to get out the bed. I had cramps and stomach pain. After that, I had achiness in my knees. Today is the first day that my arm is not sore. I didnt even want to go out yesterday due to weakness.
Arm started to hurt at injection site in the evening , then feeling somewhat achy & headachy.  Progressed to chills, body aches, fever, joint pain, and minor nausea through a good part of the night.  This morning I still feel headachy and have a low fever.  Have not taken any pain reducers.
PATIENT RECEIVED PFIZER COVID VACCINE 10/23/21.  ON 10/24/21. PATIENT  EXPERIENCED NAUSEA, FEVER, CHILL, SWOLLEN LYMPH NODE,  BRUISES AT THE INJECTION SITE. TYLENOL WAS EFFECTIVE IN RELEIVING THE SYMPTOMS. THE  LYMPH NODE SWEELING IS GOING DOWN AS OF 10/28/21
Approx. 4 hours, post vax, a rash started and the pt complained of nausea and vomiting, severe headache and swelling in the right arm and breast. Her right jaw became very sore, stiff and tingling began in fingers of right hand. Injection site was hard, swollen and had dark bruising. It was painful to touch. She took Benadryl with only small improvement. Ice pack was used to the injection site. Is starting to feel better.
pt came to Vaccination clinic to get second dose of covid vaccine.  Pt had gotten Moderna for the first vaccine and checked the box for Moderna.  It was missed by vaccine administrator, she thought that all were confirmed Pfizer second vaccines on this date.  Pt received Pfizer vaccine as second dose.  Notified that patent was administered Moderna vaccine on 1/15/21 and Pfizer on 2/13/21. Patient was given the wrong 2nd vaccine. Chart review states given by Immunization Clinic staff.
Very bad headache; Chills; Wants to vomit; First dose was administered on 06Feb2021 and second dose was on 31Mar2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered on 06Feb2021 and second dose was on 31Mar2021), HEADACHE (Very bad headache), CHILLS (Chills) and NAUSEA (Wants to vomit) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Headache. Concomitant products included IBUPROFEN for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered on 06Feb2021 and second dose was on 31Mar2021). On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Very bad headache), CHILLS (Chills) and NAUSEA (Wants to vomit). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was administered on 06Feb2021 and second dose was on 31Mar2021) had resolved and HEADACHE (Very bad headache), CHILLS (Chills) and NAUSEA (Wants to vomit) outcome was unknown.            No treatment information was provided.
Received dose on 1/20/2021 at 0818 by 1400 had a horrible headache. At 2100 started having body aches all over body. Injection site pain as well. On 1/21/2021 at 0500 began having chills and running a fever of 102.4.  The head ache subsided around 1800.  The body aches and fever were gone by 0700 on 1/22/2021.  At this point (1/22/2021 1450) just exhausted, but no other aches or pains.  During the time of the head ache initially took Tylenol which did nothing.  Then took a low dose of Ibuprofen which took an edge off.
Got Covid 19 SARS on August 19 2021. No symptoms . Have gotten a sinus infection. Was put on Antibiotics.  Just thought the loss of smell and taste was because of sinus infection,
Patient stated she felt tingling in left hand followed by tingling in right hand.  This resolved quickly per patient.  Patient then reported a sensation in the top/back of throat.  Vital signs checked.  Blood pressure 110/78, HR 68, RR 20.  Patient denies chest pain, shortness of breath, headache or feeling dizzy.  No rash or swelling observed.  Patient's color is pink, warm and dry throughout.  All symptoms resolved at 11:20.  Patient encouraged to call brother-in-law for a ride home. Patient given water to drink and observed until 11:35.
No additional AE; The patient received PROQUAD at age 3 instead of 4; This spontaneous report was received from a licensed vocational nurse referring to a 3-year-old patient whose gender was not specified.    No information regarding the patient's pertinent medical history, concurrent conditions, concomitant medication, or drug reactions/allergies was provided. On 11-SEP-2018, the patient received varicella virus vaccine live (Oka/Merck) (VARIVAX) at the age of 13-months-old (historical vaccine).  On 19-FEB-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (lot number S009759 verified as valid, expiration date reported and validated as 27-SEP-2020) for prophylaxis (administered dose, vaccination scheme, route and anatomical location of administration were not reported), at the age of 3 instead of age 4, as recommended in the prescribing information (product administered to patient of inappropriate age). No additional adverse event (AE) reported.
Pt. had received his vaccines, and at check out, pt. fainted.  He hit his right parietal/occipital area on the linoleum floor from a standing position.  The nurses reported some jerky motions briefly after the head injury.  He was assessed immediately afterwards by myself and looked pale in color and was conscious.  There was no signs of external injury of his scalp.  Patient was allow to lay in the recumbent position for a few minutes.  He was sat up and given water and Sprite to drink.  I reassessed him three times afterwards.  The second time he had complained of red spots in his vision to the nurses which had resolved on my assessment.  He had some blurriness of vision.  The third time he complained of a HA and was given ibuprofen 300 mg.   The blurriness of vision had resolved.   Prior to discharge, pt. was conversant.   His was discharged home with his mother to observe him for the next 24 hours.   Mother reported several episodes of vomiting after leaving office. Advised to proceed to the local Emergency Room.  Arrived there at 1232pm for evaluation.
Onset at 14 hours - malaise, fever, arthralgias for 36 hours Onset at 36 hours - Facial burning, redness, swelling
Had itching on back about 5 hours after injection.  Continued itching and noticed hives on back around 22:00.  Took over the counter antihistimine.  Stated she still had hives on back, neck, stomach  and was itching this morning when she called me at appr. 09:00.  Reported no Shortness of breath at any time, but did have a few heart palptations around 17:00 (when she first starting noticeing the itching).
Patient came to the pharmacy to get his first Moderna COVID vaccine today with his mom. After 15 minutes after receiving vaccine, he stated he felt dizziness, warmness, and flushing. I was able to elevate his feet and provide some cold water for him. After 10 minutes, he stated he felt his airway was getting closed and tongue was getting swollen. We decided to call 911 and provided Benadryl 50mg and Epipen for him. His blood pressure was 114/90 when EMS arrived. Since his vital was normal, EMS gave options to go to emergency room or urgent care. His mom and he chose to go to urgent care since he was getting better. I was able to follow up with his mom and he is going to take Benadryl for 2 days and follow up with Additional information for Item 18: his family physician. I will follow up with his doctor as well.
Pt developed erythematous rash, urticarial type with angiodema which began on 1/29/09 and persisted throughout 2/13/09-see picture.  There was swelling of wrists, feet  and hands, toes and dejits.
This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 56 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Apr2021 13:30 (Batch/Lot number: unknown) at the age of 56 years as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious) with onset 14Apr2021, outcome "not recovered", described as "tingling in body/burning tingling she is experiencing is Paresthesia". Therapeutic measures were taken as a result of paraesthesia. Additional Information: Description: Tingling in body: Caller stated this started in her chest, arms, and head and then she took a Benadryl which seemed to help. Caller stated she is still kind of getting tingling in her back and foot which comes and goes and is still there. Caller stated she is scared to get the second shot and worried about possibly having nerve damage. Caller stated she thinks the technical name for the burning tingling she is experiencing is Paresthesia. Caller stated the outcome is not worse except it has spread to foot and leg and she is not sure it is somewhere between the same and better. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
INJECTION SITE IS HARD AS A ROCK; GENERALLY DOES NOT FEEL WELL; ARMS HURT WHILE TRYING TO USE THEM; INJECTION SITE DOUBLE IN SIZE; INJECTION SITE BRIGHT RED; FEVER; FEELING WEAK; HURTS ALL OVER BODY; BONES ACHING (HAS ARTHRITIS); LEFT ARM USELESS; TROUBLE SLEEPING; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included raynaud's disease, lupus, arthritis, penicillin allergy, and red dye 40 allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, and expiry: UNKNOWN) dose was not reported, administered on left arm on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced left arm useless. On 24-MAR-2021, the subject experienced trouble sleeping. On 24-MAR-2021, the subject experienced hurts all over body. On 24-MAR-2021, the subject experienced feeling weak. On 24-MAR-2021, the subject experienced bones aching (has arthritis). On 24-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103 C. On 25-MAR-2021, the subject experienced injection site is hard as a rock. On 25-MAR-2021, the subject experienced generally does not feel well. On 25-MAR-2021, the subject experienced arms hurt while trying to use them. On 25-MAR-2021, the subject experienced injection site double in size. On 25-MAR-2021, the subject experienced injection site bright red. Laboratory data included: Body temperature (NR: not provided) 101.5 C. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from feeling weak, injection site is hard as a rock, arms hurt while trying to use them, generally does not feel well, fever, bones aching (has arthritis), hurts all over body, left arm useless, injection site double in size, injection site bright red, and trouble sleeping. This report was non-serious.
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had been administered dose of GARDASIL on 02-APR-2013 (lot number: H011350; exp date: 21-FEB-2015) (dose, frequency, route and site of administration were not reported). No adverse event was reported. This is one of the reports from the same source. Additional information is not expected.
Blurred vision; fatigue; dizziness; tachycardia; arm soreness; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EJ 1685), via an unspecified route of administration in the left arm on 20Dec2020 08:00 at a single dose for covid-19 immunization. Medical history included prediabetes, spinal stenosis of right back, allergies in penicillin, sulfa and yellow jacket venom. Concomitant medication included gabapentin, metformin, paracetamol (TYLENOL), diclofenac (DICLOFENAC), zinc and vitamins. On 20Dec2020 20:00, 12 hours after vaccine administration, the patient experienced blurred vision, fatigue, dizziness, tachycardia and arm soreness. The patient did not receive treatment for the events. The patient had not tested positive for COVID post vaccination. The outcome of the events was recovered on unspecified date.
Information has been received from a licensed visiting nurse (LVN) for the pregnancy registry for Gardasil concerning a 20 year old female with abdominal pain and inguinal lymphadenopathy (treated with doxycline therapy) and  a history of recurrent upper respiratory sinus infections who on 30-NOV-2006 was vaccinated with the first dose of Gardasil. On 01-FEB-2007, the patient was vaccinated with the second dose of Gardasil. On 09-MAY-2007, the patient was seen in her physician's office with a complaint of sinus congestion. On this visit, the patient reported that she was pregnant, and had seen her gynecologist one month ago. The patient's outcome was unknown. Additional information has been requested. This is in follow-up to report(s) previously submitted on 6/14/2007. Follow up phone call information was obtained from a licensed vocational nurse who reported that the patient vaginally delivered a healthy and normal infant, full-term, without complications. No additional information is expected.
Vaccines given that morning and by that evening has a slight fever. Then had prolonged seizure (15-20 minutes). Transported from local hospital to PICU at another hospital due to prolonged postictal state and hypoventilation.
fine after injection unitl 1/19 then site swelling, and itching.  advised to contact PCP.  Using topical cream for itching and ice
had a heavy menstrual bleeding for 3 weeks following the first dose, very large clots; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received the first dose of bnt162b2 (BNT162B2, Solution for injection), via an unspecified route of administration, administered in Arm Left on an unspecified date (Lot Number: EW0176) as 1ST DOSE, SINGLE for COVID-19 immunization. The vaccine was administered at a pharmacy or drug store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history was not reported. The patient was not pregnant. The patient had no concomitant medications. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. The patient reported she had a heavy menstrual bleeding for 3 weeks following the first dose, very large clots on 09Apr2021 15:00. Outcome of the event was not recovered.
Patient presented to the ED and was subsequently hospitalized for Cellulitis of left lower extremity within 6 weeks of receiving COVID vaccination.
Body shakes, fever, cold chills, light sensitivity, nausea persisting for three days. Following the second dose, I became increasingly more forgetful and have developed a "brain fog" which makes it difficult to find the right words for sentences/am confused about trying to discern things from one another. I could have a thought and be trying to communicate something and the words would elude me. This has never happened to me prior to the COVID19 vaccine. I also began to experience a shortness of breath when trying to climb stairs or exert myself physically, which has also persisted since the second dose.
Patient states that she woke up this morning, 9/26/2012, with an itching sensation at the vaccination site. Palm sized redness noted around the vaccination site and scattered red blotches noted to the posterior left arm. Red blotches also noted above the shoulder, close to the neck. She states that it "itches very badly" and is warm to the touch.
a first dose of ROT ATEQ was administered to a patient at 28 weeks old prior to realizing it was not indicated to be given after 12 weeks of age; This spontaneous report as received from a physician refers to a 30-week-old (reported as 28-week-old, but calculated as 30-week-old based on date of birth) patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies was provided.  On 31-JAN-2022, prior to realizing that the first dose was not indicated to be given after 12 weeks of age, the patient was vaccinated with the first dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # 1742078, expiry date 06-JUL-2022, 2 ml by mouth, for prophylaxis (product administered to patient of inappropriate age).
When I had my annual flu vaccine, the injection was unusually painful. The soreness in my left deltoid has not gotten better over the past year. My understanding is there are others experiencing the same symptoms. I do not want to get another flu vaccine and would like to know how to decline the vaccine.
REASON FOR CONSULT ICU-ID  is following patient for fever and leukocytosis   EVENTS OVER THE PAST 24 HOURS:    We were asked to see patient in the setting of recent fever and new leukocytosis.   He reports that for the last couple of days he has been feeling unwell, like he has the flu.  He has myalgias, arthralgias, fevers, sweats, mild cough, and small amount of nasal drainage.  No nasal congestion, shortness of breath, new rashes, diarrhea, abdominal pain, or other specific complaints.   He is vaccinated for COVID-19.  He recently received the influenza vaccine after admission on the morning of 10/20.  He reports a positive exposure to his mother who had RSV (unclear exact timing).  Had negative COVID-19 swab on 10/18.
Patient complained of red, inflamed, itching nodule on back of arm. Dr instructed patient to take BENADRYL & use cool compress.
This spontaneous report as received from a licensed practical nurse, refers to an unknown number of patients of unknown age and gender. On an unknown dates, the patients were inadvertently vaccinated with RECOMBIVAX HB (lot #, expiration date, dose and route were not reported), that had been improperly stored. No adverse effects reported. This is one of several reported received from the same source. Additional information is not expected, because there was no consent to contact a physician.